Life Science News

RSS

Thermo Fisher Scientific 2010 revenues increase 7% to $10.79 billion

Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2010.

From Thermo Fisher Scientific Inc. 2 Feb 2011

PerkinElmer announces release of 200th umbilical cord blood stem cell unit

PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that its family cord blood banking business, ViaCord, has released its 200th umbilical cord blood stem cell unit for treatment purposes. The 200th unit will be used in a clinical trial intended to treat cerebral palsy with a re-infusion of a child's own umbilical cord stem cells.

From PerkinElmer 1 Feb 2011

FDA grants pre-market clearance for SBi's rHead Extended Stem

Small Bone Innovations, an orthopedics company focused exclusively on serving patients and their physicians with technologies and treatments for joint repair and trauma reconstruction around the small bones & joints of the thumb, fingers, hand, wrist, elbow, toes and foot & ankle announced that it has received 510(k) pre-market clearance notification from the U.S. Food and Drug Administration for the radial Head Extended Stem to be used in the correction of complex elbow instabilities and/or elbow reconstruction.

From Olympus Life Science Solutions 24 Jan 2011

PerkinElmer introduces next generation DNA sequencing and data analysis services

PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of its next generation DNA sequencing and data analysis services, to enable researchers to better explore the genomic origins of disease.

From PerkinElmer 24 Jan 2011

inVentiv Health to acquire Campbell Alliance and i3

inVentiv Health, Inc., a leading provider of outsourced clinical development, launch and commercialization services to the global healthcare industry, today announced that it has signed a definitive agreement to acquire Campbell Alliance, a leading management consulting firm specializing in serving the pharmaceutical and biotech industries. Yesterday, inVentiv announced that it has signed a definitive agreement to purchase i3 from Ingenix.

From Thermo Fisher Scientific Inc. 21 Jan 2011

Thermo Fisher Scientific announces extension of tender offer for Dionex

Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its previously announced tender offer to acquire all of the outstanding shares of Dionex Corporation for $118.50 per share in cash ("the Offer") has been extended and will now expire at 12:00 midnight, New York City time, at the end of Wednesday, February 16, 2011, unless further extended.

From Thermo Fisher Scientific Inc. 14 Jan 2011

Affymetrix enters distribution agreement with Fisher Scientific for GeneAtlas System

Affymetrix, Inc. today announced that it has signed a distribution agreement with Fisher Scientific, Inc., part of Thermo Fisher Scientific, to distribute the GeneAtlas™ System and its related consumables through the Fisher Scientific channel throughout the United States and Canada.

From Thermo Fisher Scientific Inc. 12 Jan 2011

Thermo Fisher Scientific announces expiration of HSR waiting period for Dionex acquisition

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the expiration of the mandatory, pre-merger waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"), relating to its offer to acquire Dionex (NASDAQ: DNEX).

From Thermo Fisher Scientific Inc. 10 Jan 2011

Thermo Fisher Scientific acquires Lomb Scientific

Thermo Fisher Scientific Inc., the world leader in serving science, has completed its previously announced acquisition of Lomb Scientific, a well-known provider of laboratory chemicals, consumables and instruments in Australia and New Zealand.

From Thermo Fisher Scientific Inc. 27 Dec 2010

Bruker closes Sigma ElectroOptics acquisition

Bruker today announced the signing of an agreement with simultaneous closing of the acquisition of Sigma ElectroOptics GmbH ('Sigma'), based in Hamburg, Germany. Sigma's 2010 revenue is expected to be about one million Euro (approximately $1.3 million). Financial details of the transaction were not disclosed. Sigma will be integrated into the Bruker Optics infrared and Raman spectroscopy division in Ettlingen, Germany.

From Bruker Optics 22 Dec 2010

Roche launches new xCELLigence System RTCA HT Instrument

The new xCELLigence System RTCA HT Instrument from Roche Diagnostics rounds out the company's portfolio in real-time cell analysis with a high-throughput product. The new instrument merges the power and flexibility of xCELLigence System technology with high-throughput analyses and workflows for automated screening applications.

From Roche Diagnostics Limited 14 Dec 2010

Panasonic to manufacture electronic lenses for PixelOptics' electronic focusing eyeglasses

PixelOptics of Roanoke, Virginia USA announced today that Panasonic Healthcare Co., Ltd. of Ehime, Japan will manufacture electronic lenses for PixelOptics' electronic focusing eyeglasses named emPower!™. The emPower! eyeglasses focus faster than the blink of an eye, have no moving parts, and change focus without making a sound. In March of 2010 at Vision Expo East in New York, New York, Pixel and Panasonic announced that they have been working together for the last two plus years to develop and optimize Pixel's electronic lenses.

From PHC Europe B.V. 13 Dec 2010

Size exclusion chromatography illuminates protein crystallization

Understanding membrane protein crystallization is one of the main goals of molecular biology studies aimed at the structural characterization of proteins.

From Malvern Panalytical 7 Dec 2010

Fluxion Biosciences announces launch of new BioFlux 1000Z system for live cell imaging

Fluxion Biosciences, Inc. announced that the new BioFlux 1000Z system for live cell imaging will be launched at the 50th American Society for Cell Biology Annual Meeting to be held December 11-15, 2010 in Philadelphia, PA. The BioFlux 1000Z is the latest addition to the BioFlux product family of instruments for cellular analysis under controlled shear flow.

From Fluxion Biosciences 7 Dec 2010

Olympus PlasmaButton- vaporization technology now usable with Gyrus ACMI SuperPulse- Generator platform

Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products among other core businesses, announced today that its revolutionary PlasmaButton- vaporization technology can now be used with the Gyrus ACMI SuperPulse- Generator platform. Together, the PlasmaButton electrode and SuperPulse Generator provide physicians and patients with a new, virtually bloodless treatment option for benign prostate hyperplasia (BPH) or enlarged prostate.

From Olympus Life Science Solutions 3 Dec 2010

$Bruker’s AcuityXR with ContourGT optical surface profilers break diffraction limit$

Bruker’s AcuityXR with ContourGT optical surface profilers break diffraction limit

Bruker Corporation announced today at the Materials Research Society (MRS) Fall 2010 Meeting the AcuityXR™, a novel optical surface profiler mode that combines unique, patent-pending Bruker hardware and software technology to enable select ContourGT™ non-contact, 3D optical surface profilers to break the optical diffraction limit and deliver lateral resolutions that were previously considered impossible to achieve.

From Bruker Nano Surfaces 30 Nov 2010

PerkinElmer divests Illumination and Detection Solutions business to Excelitas Technologies

PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it has completed the sale of its Illumination and Detection Solutions (IDS) business to Excelitas Technologies Corp., an affiliate of Veritas Capital Fund Management, L.L.C., a New York-based private equity firm.

From PerkinElmer 30 Nov 2010

BioNeutral signs 'Stand Still' agreement with DFB

BioNeutral Group, Inc., a specialty technology-based life science company, today announced it has signed a "Stand Still" agreement with a leading pharmaceutical company, DFB Pharmaceuticals, Inc. (DFB).

From Olympus Life Science Solutions 22 Nov 2010

NT-proBNP guided heart failure care associated with reduced cardiovascular events

Roche and study investigators from Harvard University and Massachusetts General Hospital announced today that in the PROTECT (Pro-BNP Outpatient Tailored Chronic HF Therapy) trial, a strategy of NT-proBNP guided heart failure care was independently associated with a significant reduction in total cardiovascular events, the primary composite endpoint of the study, which included worsening heart failure, heart failure hospitalization and cardiovascular related death

From Roche Diagnostics Limited 17 Nov 2010

PerkinElmer releases new Columbus Scope cellular imaging software solution for microscopy labs

PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the release of its new cellular imaging software solution, the Columbus® Scope platform, designed specifically for microscopy labs.

From PerkinElmer 17 Nov 2010